Breaking news in spinal cord injury research FDA approved phase I clinical trial of human, autologous Schwann cell transplantation in patients with spinal cord injuries

Research output: Contribution to journalArticle

5 Citations (Scopus)
Original languageEnglish
Pages (from-to)1685-1687
Number of pages3
JournalNeural Regeneration Research
Volume7
Issue number22
DOIs
StatePublished - Aug 8 2012

Fingerprint

Clinical Trials, Phase I
Schwann Cells
Cell Transplantation
Spinal Cord Injuries
Research

ASJC Scopus subject areas

  • Developmental Neuroscience

Cite this

@article{cc8667f083f14962aedf873354c63c2a,
title = "Breaking news in spinal cord injury research FDA approved phase I clinical trial of human, autologous Schwann cell transplantation in patients with spinal cord injuries",
author = "Xiao-Ming Xu",
year = "2012",
month = "8",
day = "8",
doi = "10.3969/j.issn.1673-5374",
language = "English",
volume = "7",
pages = "1685--1687",
journal = "Neural Regeneration Research",
issn = "1673-5374",
publisher = "Editorial Board of Neural Regeneration Research",
number = "22",

}

TY - JOUR

T1 - Breaking news in spinal cord injury research FDA approved phase I clinical trial of human, autologous Schwann cell transplantation in patients with spinal cord injuries

AU - Xu, Xiao-Ming

PY - 2012/8/8

Y1 - 2012/8/8

UR - http://www.scopus.com/inward/record.url?scp=84919918509&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919918509&partnerID=8YFLogxK

U2 - 10.3969/j.issn.1673-5374

DO - 10.3969/j.issn.1673-5374

M3 - Article

VL - 7

SP - 1685

EP - 1687

JO - Neural Regeneration Research

JF - Neural Regeneration Research

SN - 1673-5374

IS - 22

ER -